Quick Answer
vTv Therapeutics Inc. reported Operating Income of -$32.81 million for fiscal year 2025.
vTv Therapeutics Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$32.81M | -35.7% |
| 2024 | -$24.18M | +5.2% |
| 2023 | -$25.50M | -13.1% |
| 2022 | -$22.54M | -4.1% |
| 2021 | -$21.66M | -82.8% |
| 2020 | -$11.85M | +43.3% |
| 2019 | -$20.89M | -5.4% |
| 2018 | -$19.82M | +60.9% |
| 2017 | -$50.68M | +7.9% |
| 2016 | -$55.02M | -44.3% |
| 2015 | -$38.14M | -32.0% |
| 2014 | -$28.90M | +19.4% |
| 2013 | -$35.83M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$10.70M | -64.4% | -38.6% |
| June 30, 2025 | -$7.72M | -7.9% | -18.7% |
| March 31, 2025 | -$6.50M | -15.6% | +0.0% |
| September 30, 2024 | -$6.51M | -21.2% | +9.1% |
| June 30, 2024 | -$7.16M | +10.6% | -27.2% |
| March 31, 2024 | -$5.63M | +24.2% | -4.8% |
| September 30, 2023 | -$5.37M | +5.6% | +32.9% |
| June 30, 2023 | -$8.00M | -98.7% | -7.7% |
- vTv Therapeutics Inc. showed a decrease of -35.7% in Operating Income compared to the prior fiscal year.
- Over the 2013–2025 period, vTv Therapeutics Inc.’s operating income has grown by 8.4% (from -$35.83 million to -$32.81 million).
- The most recent figure is from vTv Therapeutics Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 10, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: